Drugs / Purified Exosome Product
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06319287 Comparator | Feb 2024 → Apr 2025 | ulcer of lower limbs | Rion Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purified Exosome Product | “Biological: PEP (Purified Exosome Product) / TISSEEL” NCT06319287 ↗ |
| Known as | PEP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06319287 ↗ |
| Route | Topical | “Topically Applied PEP-TISSEEL” NCT06319287 ↗ |